BSEBoard Meeting31 Jul 2026 · 31 Jul 2026, 09:43 pm
Themis Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the Standalone and Consolidated ....
Themis Medicare Ltd · 530199
✦ AI SummaryResults
Themis Medicare Ltd has scheduled a Board meeting on 13th August 2026 to consider and approve the standalone and consolidated un-audited financial results for the quarter ended 30th June 2026 and limited review reports of the statutory auditors thereon.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Themis Medicare Ltd - 530199 - Board Meeting Intimation for Approval Of Standalone And Consolidated Un-Audited Financial Results For The Quarter Ended On 30Th June, 2026 And Limited Review Reports Of The Statutory Auditors Thereon
Attachments (1)
📄pdf
Download →
9c9c425f-2395-4821-a113-5422739fecc4.pdf
View document text
TML/BSE/NSE/2026-27/16 31st July, 2026
Corporate Relationship Department Listing Department
BSE Limited National Stock Exchange of India Limited
Floor 25, Phiroze Jeejeebhoy Towers Exchange Plaza,
Dalal Street, Mumbai- 400001 Bandra Kurla Complex,
Scrip Code – 530199 Bandra (East), Mumbai- 400051
Symbol: THEMISMED
Dear Sir / Madam,
Sub: Intimation of date of Board meeting of the Company under Regulation 29 of the SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015:
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of Themis
Medicare Limited is scheduled to be held on Thursday, 13th August, 2026 to consider and
approve the Standalone and Consolidated Un-Audited Financial Results for the quarter
ended on 30th June, 2026 and Limited Review Reports of the Statutory Auditors thereon;
Further, we would like to inform you that as per the Company’s Code of Conduct for
Prevention of Insider Trading pursuant to the SEBI (Prohibition of Insider Trading) Regulations,
2015, the Company had intimated its ‘Designated Persons’ that the Trading Window would
remain closed from 01st July, 2026 till the expiry of 48 hours from the date of publication of the
said financial results of the Company.
This is for your information and record please.
Thanking you,
Yours faithfully,
For Themis Medicare Ltd
Dr. Dinesh Patel
Chairman
DIN: 00033273
Themis Medicare Limited
Corporate Office: 11/12 Udyog Nagar, S V Road, Goregaon (W), Mumbai – 400 104, India
*Tel.: 91-22-67607080*Fax: 91-22-67607070/ 28746621
Regd. Office: Plot No. 69-A, G.I.D.C., Industrial Estate, Vapi-Gujarat
CIN No.: L24110GJ1969PLC001590 *Tel/ Fax No.: Regd. Off.: 0260-2431447/ 2430219
*E-mail: themis@themismedicare.com*Website: www.themismedicare.com